YOUR BUSINESS AUTHORITY
Springfield, MO
Pfizer has ended development of a twice-daily weight loss pill.
Company officials said the pill, called danuglipron, caused significant weight loss in trial patients. However, they experienced high rates of adverse side effects.
Pfizer plans to develop a once-daily version of the pill starting next year.
Read more from CNBC.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
Trump, fast-food companies among targets of X redirects
Stockton district names next superintendent
State awards Springfield $4.6M for wastewater system improvements
Council modifies data center definitions bill, extends moratorium into next year